Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Onco-Innovations Ltd. ( (TSE:ONCO) ) has provided an announcement.
Onco-Innovations Limited has filed a preliminary base shelf prospectus with securities regulators in several Canadian provinces, a move that, once finalized, will enable the company to issue a range of securities including common shares, debt, warrants, subscription receipts and units over a 25‑month period. The filing is designed to give the cancer-focused biotech greater financial flexibility to raise capital as needed, positioning it to support future research, development and potential commercialization initiatives, although there is no assurance that any offerings will ultimately be undertaken under this prospectus.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based oncology-focused company dedicated to cancer research and treatment. The company’s mission is to advance the prevention and treatment of cancer through pioneering research and innovative solutions, underpinned by an exclusive worldwide licence to patented technology targeting solid tumours.
Average Trading Volume: 31,475
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$82.58M
See more data about ONCO stock on TipRanks’ Stock Analysis page.